{"id":"https://openalex.org/W2058536244","doi":"https://doi.org/10.1093/eurheartj/ehp601","title":"Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial","display_name":"Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-22","ids":{"openalex":"https://openalex.org/W2058536244","doi":"https://doi.org/10.1093/eurheartj/ehp601","mag":"2058536244","pmid":"https://pubmed.ncbi.nlm.nih.gov/20097702","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2821630"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehp601","doi":"https://doi.org/10.1093/eurheartj/ehp601","is_oa":true,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehp601","pdf_url":"https://academic.oup.com/eurheartj/article-pdf/31/4/480/17049161/ehp601.pdf","source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2058536244"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/eurheartj/article-pdf/31/4/480/17049161/ehp601.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049272753","display_name":"Evan A. Stein","orcid":"https://orcid.org/0000-0001-7147-5394","observed_orcids":["https://orcid.org/0000-0001-7147-5394"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Evan A. Stein","raw_affiliation_strings":["Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA. esteinmrl@aol.com","Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA. esteinmrl@aol.com","institution_ids":[]},{"raw_affiliation_string":"Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089409959","display_name":"Eli M. Roth","orcid":"https://orcid.org/0000-0002-3367-5704","observed_orcids":["https://orcid.org/0000-0002-3367-5704"]},"institutions":[{"id":"https://openalex.org/I4210090186","display_name":"Sterling Research Group","ror":"https://ror.org/009prea33","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210090186"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eli M. Roth","raw_affiliation_strings":["Sterling Research Group, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sterling Research Group, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I4210090186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033180130","display_name":"James M. Rhyne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132010","display_name":"Louisville Metabolic and Atherosclerosis Research Center","ror":"https://ror.org/030y83r80","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210132010"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James M. Rhyne","raw_affiliation_strings":["The Lipid Center, Statesville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Lipid Center, Statesville, NC, USA","institution_ids":["https://openalex.org/I4210132010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017791662","display_name":"Tracy Burgess","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tracy Burgess","raw_affiliation_strings":["Hoffmann-La Roche Inc., Nutley, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., Nutley, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075595313","display_name":"David G. Kallend","orcid":"https://orcid.org/0000-0003-3680-285X","observed_orcids":["https://orcid.org/0000-0003-3680-285X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Kallend","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089418361","display_name":"Jennifer G. Robinson","orcid":"https://orcid.org/0000-0002-4432-4352","observed_orcids":["https://orcid.org/0000-0002-4432-4352"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer G. Robinson","raw_affiliation_strings":["Lipid Research Clinic, The University of Iowa, Iowa City, IA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lipid Research Clinic, The University of Iowa, Iowa City, IA, USA","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5049272753"],"corresponding_institution_ids":[],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":{"value":5240,"currency":"EUR","value_usd":5922},"fwci":17.5542,"has_fulltext":true,"cited_by_count":114,"citation_normalized_percentile":{"value":0.99446945,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"31","issue":"4","first_page":"480","last_page":"488"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dalcetrapib","display_name":"dalcetrapib","score":1.0},{"id":"https://openalex.org/keywords/cholesteryl-ester-transfer-protein-inhibition","display_name":"cholesteryl ester transfer protein inhibition","score":0.8399999737739563},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8840000033378601},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.953000009059906},{"id":"https://openalex.org/keywords/mesenteric-lymph-nodes","display_name":"mesenteric lymph nodes","score":0.8029999732971191},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.9470000267028809},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.8230000138282776},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6970000267028809},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7179999947547913},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8080000281333923},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9635769724845886},{"id":"https://openalex.org/C45505151","wikidata":"https://www.wikidata.org/wiki/Q424706","display_name":"Cholesterylester transfer protein","level":4,"score":0.8213487267494202},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.5784841775894165},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5578664541244507},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5259031653404236},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4631931185722351},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4589451551437378},{"id":"https://openalex.org/C2779720271","wikidata":"https://www.wikidata.org/wiki/Q179422","display_name":"Lymph","level":2,"score":0.4470422863960266},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3617092967033386},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36134934425354004},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3192838728427887},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.1826786994934082},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1243634819984436},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004952","descriptor_name":"Esters","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008206","descriptor_name":"Lymphatic Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008643","descriptor_name":"Mesentery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013438","descriptor_name":"Sulfhydryl Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013438","descriptor_name":"Sulfhydryl Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/eurheartj/ehp601","doi":"https://doi.org/10.1093/eurheartj/ehp601","is_oa":true,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehp601","pdf_url":"https://academic.oup.com/eurheartj/article-pdf/31/4/480/17049161/ehp601.pdf","source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2821630","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2821630/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Heart J","raw_type":"Text"},{"id":"pmid:20097702","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20097702","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:open-archive.highwire.org:ehj:ehp601v1","doi":null,"is_oa":false,"landing_page_url":"http://eurheartj.oxfordjournals.org/cgi/content/short/ehp601v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1093/eurheartj/ehp601","doi":"https://doi.org/10.1093/eurheartj/ehp601","is_oa":true,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehp601","pdf_url":"https://academic.oup.com/eurheartj/article-pdf/31/4/480/17049161/ehp601.pdf","source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"},{"id":"https://openalex.org/F4320310466","display_name":"Universit\u00e4t Basel","ror":"https://ror.org/02s6k3f65"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2058536244.pdf","grobid_xml":"https://content.openalex.org/works/W2058536244.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1860487341","https://openalex.org/W1973355122","https://openalex.org/W2014137262","https://openalex.org/W2014558113","https://openalex.org/W2038416334","https://openalex.org/W2047410519","https://openalex.org/W2048760408","https://openalex.org/W2058867908","https://openalex.org/W2063992255","https://openalex.org/W2064707131","https://openalex.org/W2073638666","https://openalex.org/W2101777997","https://openalex.org/W2106624199","https://openalex.org/W2117092539","https://openalex.org/W2117416880","https://openalex.org/W2123337267","https://openalex.org/W2130581607","https://openalex.org/W2134811220","https://openalex.org/W2141210634","https://openalex.org/W2154251179","https://openalex.org/W2156281737","https://openalex.org/W2336122760"],"related_works":["https://openalex.org/W96744565","https://openalex.org/W2028839578","https://openalex.org/W2118825330","https://openalex.org/W2126666720","https://openalex.org/W1542346667","https://openalex.org/W2057930014","https://openalex.org/W2106839593","https://openalex.org/W2026584835","https://openalex.org/W2084336658","https://openalex.org/W1981220884"],"abstract_inverted_index":{"AIMS:":[0],"Co-primary":[1],"objectives":[2],"were":[3,94,99],"to":[4,31,48,174],"evaluate":[5,32],"dalcetrapib":[6,49],"(JTT-705/RO4607381),":[7],"which":[8],"targets":[9],"cholesteryl":[10],"ester":[11],"transfer":[12],"protein":[13],"(CETP),":[14],"effects":[15],"on":[16,163],"high-density":[17],"lipoprotein":[18],"cholesterol":[19],"(HDL-C)":[20],"in":[21,35,141,182],"participants":[22,45],"with":[23,44,62],"coronary":[24],"heart":[25],"disease":[26],"or":[27,59,186],"risk":[28],"equivalents":[29],"and":[30,91,123,149],"potential":[33],"changes":[34,90,181],"mesenteric":[36],"lymph":[37,97,164,183],"nodes.":[38],"METHODS":[39],"AND":[40],"RESULTS:":[41],"Double-blind":[42],"trial":[43],"randomized":[46],"(2:1)":[47],"900":[50,169],"mg/day":[51],"(higher":[52],"than":[53],"600":[54],"mg":[55,170],"phase":[56],"III":[57],"dose)":[58],"placebo,":[60],"both":[61],"atorvastatin,":[63],"for":[64,83,172],"24":[65],"weeks":[66,176,196],"(n":[67,86],"=":[68,87],"135;":[69],"one":[70],"without":[71],"post-baseline":[72],"efficacy":[73],"data":[74],"was":[75],"excluded":[76],"from":[77],"intent-to-treat":[78],"population);":[79],"a":[80],"subset":[81],"continued":[82],"24-week":[84],"extension":[85],"77).":[88],"Lipid":[89],"safety":[92,188],"parameters":[93,145],"assessed.":[95],"Mesenteric":[96],"nodes":[98],"evaluated":[100],"by":[101],"magnetic":[102],"resonance":[103],"imaging.":[104],"Dalcetrapib":[105,133,156,168,190],"increased":[106,124,192],"HDL-C":[107,193],"(33.4%,":[108],"Week":[109,112,118,121,128,131],"24;":[110,119,129],"33.8%,":[111],"48),":[113,122],"decreased":[114],"CETP":[115],"activity":[116],"(-53.5%,":[117],"-56.5%,":[120],"apolipoprotein":[125],"A-I":[126],"(11.4%,":[127],"16.4%,":[130],"48).":[132],"showed":[134,177],"no":[135,158,178],"clinically":[136,160,179],"relevant":[137,161,180],"differences":[138],"vs.":[139],"placebo":[140],"adverse":[142],"events,":[143],"laboratory":[144],"including":[146,152],"aldosterone,":[147],"electrocardiograms,":[148],"vital":[150],"signs":[151],"blood":[153],"pressure":[154],"(BP).":[155],"had":[157],"measurable,":[159],"effect":[162],"node":[165],"size.":[166],"CONCLUSION:":[167],"administered":[171],"up":[173],"48":[175,195],"nodes,":[184],"BP,":[185],"other":[187],"parameters.":[189],"effectively":[191],"over":[194],"of":[197],"treatment.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2058536244","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":29}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
